Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast

被引:34
作者
Berner, HS [1 ]
Nesland, JM [1 ]
机构
[1] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
关键词
infiltrating lobular carcinoma; immunohistochemistry; CD44;
D O I
10.1023/A:1006417412046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expression of CD44 has been shown to correlate with the progression and prognosis of some malignant tumors. The aim of this study was to evaluate the expression of CD44 isoforms in infiltrating lobular carcinomas and analyse their potential as prognostic indicators. A panel of 39 tumors were examined for their expression of membranous and cytoplasmic CD44s, v3, v5, v6, v7 and v3-10 in the infiltrating cells, by immunohistochemical staining. The protein positive tumors showed membranous and/or cytoplasmic staining with all antibodies used except for CD44v7, which only displayed cytoplasmic staining. Cytoplasmic expression of CD44v3 (P = 0.014) and membranous expression of v6 (P = 0.039) were significantly associated with alveolar, classical/alveolar carcinomas and mucinous/alveolar carcinomas. Furthermore, in alveolar, classical/alveolar and mucinous/alveolar carcinomas, cytoplasmic staining of CD44v5 was correlated with lymph node negative patients (P = 0.048), whereas membranous v5 was correlated with lymph positive patients (P = 0.048). In classical, classical/trabecular and trabecular carcinomas expression of membranous CD44s was significantly correlated with lymph node status (P = 0.042).
引用
收藏
页码:23 / 29
页数:7
相关论文
共 36 条
  • [1] Gains and losses of CD44 expression during breast carcinogenesis and tumour progression
    Bankfalvi, A
    Terpe, HJ
    Breukelmann, D
    Bier, B
    Rempe, D
    Pschadka, G
    Krech, R
    Böcker, W
    [J]. HISTOPATHOLOGY, 1998, 33 (02) : 107 - 116
  • [2] Beham-Schmid C, 1998, J PATHOL, V186, P383
  • [3] Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas
    Combaret, V
    Gross, N
    Lasset, C
    Frappaz, D
    Peruisseau, G
    Philip, T
    Beck, D
    Favrot, MC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 25 - 34
  • [4] Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma
    Combaret, V
    Gross, N
    Lasset, C
    Frappaz, D
    Beretta-Brognara, C
    Philip, T
    Beck, D
    Favrot, MC
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (12) : 2101 - 2105
  • [5] COMPARISON OF IMMUNOHISTOCHEMISTRY AND RT-PCR FOR DETECTION OF CD44V-EXPRESSION, A NEW PROGNOSTIC FACTOR IN HUMAN BREAST-CANCER
    DALL, P
    HEIDER, KH
    SINN, HP
    SKROCHANGEL, P
    ADOLF, G
    KAUFMANN, M
    HERRLICH, P
    PONTA, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (04) : 471 - 477
  • [6] Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia
    Dellas, A
    Schultheiss, E
    Almendral, AC
    Torhost, J
    Gudat, F
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 62 (02) : 218 - 225
  • [7] CD44 - A NEW PROGNOSTIC MARKER FOR NEUROBLASTOMA
    FAVROT, MC
    COMBARET, V
    LASSET, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (26) : 1965 - 1965
  • [8] FRIEDRICHS K, 1995, CANCER RES, V55, P5424
  • [9] CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma
    Guriec, N
    Marcellin, L
    Gairard, B
    Calderoli, H
    Wilk, A
    Renaud, R
    Bergerat, JP
    Oberling, F
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1996, 14 (05) : 434 - 439
  • [10] HAYNES BF, 1991, CANCER CELL-MON REV, V3, P347